Q/C Technologies Earnings
NASDAQ: QCLSHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
0.2784-0.0178 (-6.01%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Q/C Technologies earnings summary
In its most recent report on Nov 18, 2026 (Sep/2026), QCLS posted EPS of $-0.14.
Summary generated from market data by MetaCap's automated system. Methodology
QCLS earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Nov 18, 2026 | — | $-0.14 | — | — |
| Nov 16, 2026 | — | $-0.14 | — | — |
| Aug 12, 2026 | — | $-0.91 | — | — |
| May 15, 2026 | — | $-0.38 | — | — |
| Nov 19, 2025 | — | $-2.50 | — | — |
| Aug 19, 2025 | — | $-51.10 | — | — |
| May 15, 2025 | — | $-0.36 | — | — |
| Nov 14, 2024 | — | $-107.62 | — | — |
| Aug 19, 2024 | — | $-4.54 | — | — |
| May 15, 2024 | — | $-5.14 | — | — |
| Apr 1, 2024 | — | $-5.14 | — | — |
| Nov 14, 2023 | — | $0.37 | — | — |
| Aug 14, 2023 | — | $-3.22 | — | — |
| May 15, 2023 | — | $-1.20 | — | — |
| Mar 31, 2023 | — | $-11.45 | — | — |
| Nov 10, 2022 | — | $-0.09 | — | — |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.